Commodore Capital LP
Filing Date
Global Rank
#1,331
/ 7,976
▲ 229
Top Industry
Biotechnology
90.4%
3Y Alpha vs SPY
+1.2%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
20 quarters · since Dec 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+81.6%
SPY
+76.3%
Annualised alpha
+1.2%
Max drawdown
−53.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
34 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
7.5%
−1.7 pts
Top 5
32.3%
−6.4 pts
Top 10
58.2%
−6.8 pts
HHI
456
Diversified−81
Portfolio Trend
20 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.5% | $1,614,595,162 |
| Financial Services | 0.5% | $7,950,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| COGT | Cogent Biosciences, Inc. | +4,938,836 | 7,250,000 | $104,110,000 | |
| RLAY | Relay Therapeutics, Inc. | +3,650,000 | 17,000,000 | $88,740,000 | |
| SLNO | Soleno Therapeutics Inc | +740,000 | 1,350,000 | $91,260,000 | |
| ALKS | Alkermes plc. | +646,754 | 3,096,754 | $92,902,620 | |
| PHVS | Pharvaris N.V. | +507,043 | 2,418,476 | $60,340,976 | |
| ORKA | Oruka Therapeutics, Inc. | +333,340 | 1,753,054 | $33,711,228 | |
| TYRA | Tyra Biosciences, Inc. | +275,000 | 3,375,000 | $47,216,250 | |
| NUVL | Nuvalent, Inc. | +25,000 | 1,400,000 | $121,072,000 | |
| AGIO | Agios Pharmaceuticals, Inc. | +13,287 | 2,338,287 | $93,858,840 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.DE | −1,675,000 | 3,200,000 | $69,056,000 | |
| CNTA | Centessa Pharmaceuticals plc | −448,289 | 2,850,000 | $69,112,500 | |
| CLDX | Celldex Therapeutics, Inc. | −421,665 | 3,028,335 | $78,343,026 | |
| XENE | Xenon Pharmaceuticals Inc. | −325,000 | 2,700,000 | $108,405,000 | |
| NRIX | Nurix Therapeutics, Inc. | −168,598 | 3,780,055 | $34,927,708 | |
| PTGX | Protagonist Therapeutics, Inc | −50,000 | 1,025,000 | $68,090,750 | |
| CBIO | Crescent Biopharma, Inc. | −2,857 | 450,829 | $5,360,356 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 4,075,478 | $55,385,746 | |
| TERN | Terns Pharmaceuticals, Inc. | 5,700,000 | $42,807,000 | |
| ASMB | Assembly Biosciences, Inc. | 1,000,000 | $25,600,000 | |
| LBRX | Lb Pharmaceuticals Inc | 1,500,000 | $23,685,000 | |
| PEPG | PepGen Inc. | 2,357,319 | $10,890,813 | |
| ENTA | Enanta Pharmaceuticals Inc | 800,000 | $9,576,000 | |
| SABS | SAB Biotherapeutics, Inc. | 4,401,500 | $8,847,015 | |
| No positions match the current search. | ||||
34 positions ·
$1,622,545,162 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 1,400,000 | $121,072,000 | 7.46% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 2,700,000 | $108,405,000 | 6.68% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 7,250,000 | $104,110,000 | 6.42% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Held | 4,692,809 | $96,061,800 | 5.92% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 2,338,287 | $93,858,840 | 5.78% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 3,096,754 | $92,902,620 | 5.73% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Added | 1,350,000 | $91,260,000 | 5.62% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 17,000,000 | $88,740,000 | 5.47% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 3,028,335 | $78,343,026 | 4.83% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 2,850,000 | $69,112,500 | 4.26% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Reduced | 3,200,000 | $69,056,000 | 4.26% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 1,025,000 | $68,090,750 | 4.20% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 2,418,476 | $60,340,976 | 3.72% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
NEW | 4,075,478 | $55,385,746 | 3.41% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 3,375,000 | $47,216,250 | 2.91% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
NEW | 5,700,000 | $42,807,000 | 2.64% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 750,000 | $42,450,000 | 2.62% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 3,780,055 | $34,927,708 | 2.15% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Added | 1,753,054 | $33,711,228 | 2.08% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 1,988,084 | $33,320,287 | 2.05% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Held | 500,000 | $30,330,000 | 1.87% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
NEW | 1,000,000 | $25,600,000 | 1.58% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Held | 7,692,300 | $24,538,437 | 1.51% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
NEW | 1,500,000 | $23,685,000 | 1.46% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Held | 1,500,000 | $12,600,000 | 0.78% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Held | 290,000 | $11,521,700 | 0.71% | |
| PEPG |
PepGen Inc.
Healthcare
|
NEW | 2,357,319 | $10,890,813 | 0.67% | |
| ENTA |
Enanta Pharmaceuticals Inc
Healthcare
|
NEW | 800,000 | $9,576,000 | 0.59% | |
| SABS |
SAB Biotherapeutics, Inc.
Healthcare
|
NEW | 4,401,500 | $8,847,015 | 0.55% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Held | 5,397,488 | $8,743,930 | 0.54% | |
| PCSC |
Perceptive Capital Solutions Corp
Financial Services
|
Held | 750,000 | $7,950,000 | 0.49% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Held | 483,000 | $6,138,930 | 0.38% | |
| VTGN |
Vistagen Therapeutics, Inc.
Healthcare
|
Held | 1,575,000 | $5,591,250 | 0.34% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Reduced | 450,829 | $5,360,356 | 0.33% |